Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

merial sas, 29, avenue tony garnier, 69007 lyon, france - atenuirani virus zaraznog bronhitisa kokoši, soj h-120 - liofilizat za pripremu suspenzije - imunološki vmp - kokoši

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pliva d.o.o.sarajevo - enalapril - tableta - 10 mg/1 tableta - 1 tableta sadrži: 10 mg enalaprilmaleata

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pliva d.o.o.sarajevo - enalapril - tableta - 20 mg/1 tableta - 1 tableta sadrži: 20 mg enalaprilmaleata

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pliva d.o.o.sarajevo - enalapril - tableta - 5 mg/1 tableta - 1 tableta sadrži: 5 mg enalaprilmaleata

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bayer animal health gmbh, 51368 leverkusen, njemačka - imidakloprid - otopina za nakapavanje, za mačke i kuniće do 4 kg - mačaka (<4 kg) i kunića (kućni ljubimac, <4 kg)

Europska Unija - hrvatski - EMA (European Medicines Agency)

zoetis belgium sa - tulathromycin - antibakterijska sredstva za sistemsku uporabu - pigs; cattle; sheep - goveda: liječenje i метафилактики bolesti dišnih organa goveda (БРД), povezana je s mannheimia haemolytica, bakterija pasteurella multocida, odaberite histophilus somni i Микоплазмы бовис osjetljivi na тулатромицин. prisutnost bolesti u stadu treba biti uspostavljena prije metafilaktičkog liječenja. liječenje infektivnog goveđeg keratokonjunktivitisa (ibk) povezanog s moraxella bovis osjetljivim na tulatromicin. svinja: liječenje i метафилактики respiratorne bolesti svinja (срд), povezana je sa actinobacillus плевропневмонии, bakterija pasteurella multocida, hyopneumoniae Микоплазмы uzrokovane haemophilus parasuis i Бордетеллы bronchiseptica osjetljivi na тулатромицин. prisutnost bolesti u stadu treba biti uspostavljena prije metafilaktičkog liječenja. draxxin treba koristiti samo ako se od svinja očekuje da razviju bolest u roku od 2-3 dana. ovce: liječenje ranih stadija infektivnog pododermitisa (trbuha nogu) povezanih s virulentnim dichelobacter nodosusom koji zahtijeva sustavno liječenje.

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bayer d.o.o., radnička cesta 80, 10000 zagreb, hrvatska - emodepsid; prazikvantel - otopina za nakapavanje na kožu - malih mačaka (0,5 do 2,5 kg)

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bayer d.o.o., radnička cesta 80, 10000 zagreb, hrvatska - emodepsid; prazikvantel - otopina za nakapavanje na kožu - srednje velikih mačaka (2,5 do 5 kg)

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bayer d.o.o., radnička cesta 80, 10000 zagreb, hrvatska - emodepsid; prazikvantel - otopina za nakapavanje na kožu - velikih mačaka (5 do 8 kg)

Europska Unija - hrvatski - EMA (European Medicines Agency)

janssen-cilag international nv - danmavir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.